Canada Life’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,180
| Closed | -$13K | – | 2580 |
|
|
2021
Q3 | $13K | Hold |
2,180
| – | – | ﹤0.01% | 2494 |
|
|
2021
Q2 | $18K | Hold |
2,180
| – | – | ﹤0.01% | 2503 |
|
|
2021
Q1 | $19K | Hold |
2,180
| – | – | ﹤0.01% | 2519 |
|
|
2020
Q4 | $25K | Hold |
2,180
| – | – | ﹤0.01% | 2501 |
|
|
2020
Q3 | $23K | Hold |
2,180
| – | – | ﹤0.01% | 2419 |
|
|
2020
Q2 | $28K | Hold |
2,180
| – | – | ﹤0.01% | 2425 |
|
|
2020
Q1 | $17K | Hold |
2,180
| – | – | ﹤0.01% | 2418 |
|
|
2019
Q4 | $45K | Buy |
+2,180
| New | +$36.8K | ﹤0.01% | 2303 |
|
|
2019
Q3 | – | Sell |
-4,108
| Closed | -$50K | – | 2566 |
|
|
2019
Q2 | $50K | Buy |
4,108
+1,908
| +87% | +$22K | ﹤0.01% | 2443 |
|
|
2019
Q1 | $27K | Hold |
2,200
| – | – | ﹤0.01% | 2347 |
|
|
2018
Q4 | $24K | Hold |
2,200
| – | – | ﹤0.01% | 2521 |
|
|
2018
Q3 | $41K | Hold |
2,200
| – | – | ﹤0.01% | 2435 |
|
|
2018
Q2 | $57K | Hold |
2,200
| – | – | ﹤0.01% | 2374 |
|
|
2018
Q1 | $49K | Hold |
2,200
| – | – | ﹤0.01% | 2376 |
|
|
2017
Q4 | $55K | Hold |
2,200
| – | – | ﹤0.01% | 2339 |
|
|
2017
Q3 | $52K | Hold |
2,200
| – | – | ﹤0.01% | 2327 |
|
|
2017
Q2 | $44K | Hold |
2,200
| – | – | ﹤0.01% | 2365 |
|
|
2017
Q1 | $59K | Hold |
2,200
| – | – | ﹤0.01% | 2266 |
|
|
2016
Q4 | $42K | Buy |
+2,200
| New | +$42K | ﹤0.01% | 2367 |
|
Canada Life's FLXN Position: Q4 2021 in Review
Canada Life sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 2,180 shares — an estimated $13K sold.
Canada Life first reported a position in FLXN in Q4 2016 and held it in 19 quarters. The position peaked at $59K in Q1 2017. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- Canada Life reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- Canada Life sold 2,180 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $13K.
- Canada Life first reported a position in Flexion Therapeutics, Inc. in Q4 2016 and held it in 19 quarters.
- Canada Life's Flexion Therapeutics, Inc. position peaked at $59K in Q1 2017.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.